Skip to main navigation

We have recently updated our Privacy Policy to include information regarding the cookies we collect. By continuing to use this website you agree to our Privacy Policy and Terms of Use .

ACCEPT

Patients & Care Partners
Patients & Care Partners

Patient Advocacy

Patient Advocacy Sponsorships & Grants

Patient Support
Healthcare Providers
Healthcare Providers

Visit the Sage Medical Hub
Our Medicines
Therapeutic Focus
Therapeutic Focus

A New Approach to Brain Health Disorders

GABA & NMDA Receptors
Programs & Research
Programs & Research

Depression Franchise

Neurology Franchise

Neuropsychiatry Franchise

Pipeline

Clinical Trials

Early Access

Collaborations
About Us
About Us

Mission & Values

Corporate Governance

Our Team

Partnering

Corporate Social Responsibility

Funding & Giving
Working at Sage

Search

Sage Thoughts
Investors/Media
Clinical Trials
Contact Us

Search

Investors & Media

Quarterly Results

Investor Relations

Overview
Corporate Governance
Press Releases & Statements
Events & Presentations
SEC Filings
Annuals and Proxies
Investor FAQs
Financials & Filings
- Quarterly Results
Stock Information
Analyst Coverage
Email Alerts Subscription
Notice of Pendency of Settlement of Action

Quarterly Results

Show all

2023

Fourth Quarter

Sage Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Highlights Pipeline and Business Progress
Form 10-K

Third Quarter

Sage Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
Form 10-Q

Second Quarter

Sage Therapeutics Announces Second Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
Form 10-Q

First Quarter

Sage Therapeutics Announces First Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
Form 10-Q

2022

Fourth Quarter

Sage Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Highlights Pipeline and Business Progress
Form 10-K

Third Quarter

Sage Therapeutics Announces Third Quarter 2022 Financial Results and Highlights Pipeline and Business Progress
Form 10-Q

Second Quarter

Sage Therapeutics Announces Second Quarter 2022 Financial Results and Highlights Pipeline and Business Progress
Form 10-Q

First Quarter

Sage Therapeutics Announces First Quarter 2022 Financial Results and Highlights Pipeline and Business Progress
Form 10-Q

2021

Fourth Quarter

Sage Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Highlights Pipeline and Business Progress
Form 10-K

Third Quarter

Sage Therapeutics Announces Third Quarter 2021 Financial Results and Highlights Pipeline and Business Progress
Form 10-Q

Second Quarter

Sage Therapeutics Announces Second Quarter 2021 Financial Results and Highlights Pipeline and Business Progress
Sage Therapeutics Q2 2021 Financial Results Conference Call
Form 10-Q

First Quarter

Sage Therapeutics Announces First Quarter 2021 Financial Results and Highlights Pipeline and Business Progress
Sage Therapeutics Q1 2021 Financial Results Conference Call
Form 10-Q

2020

Fourth Quarter

Sage Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Highlights Pipeline and Business Progress
Sage Therapeutics Q4 2020 Financial Results Conference Call
Form 10-K

Third Quarter

Sage Therapeutics Announces Third Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
Sage Therapeutics Q3 2020 Financial Results Conference Call
Form 10-Q

Second Quarter

Sage Therapeutics Announces Second Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
Sage Therapeutics Q2 2020 Financial Results Conference Call
Form 10-Q

First Quarter

Sage Therapeutics Announces First Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
Sage Therapeutics Q1 2020 Financial Results Conference Call
Form 10-Q

2019

Fourth Quarter

Sage Therapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Highlights Pipeline and Business Progress
Sage Therapeutics Q4 2019 Financial Results Conference Call
Form 10-K

Third Quarter

Sage Therapeutics Announces Third Quarter 2019 Financial Results and Highlights Pipeline and Business Progress
Sage Therapeutics Q3 2019 Financial Results Conference Call
Form 10-Q

Second Quarter

Sage Therapeutics Announces Second Quarter 2019 Financial Results and Highlights Pipeline and Business Progress
Sage Therapeutics Q2 2019 Financial Results Conference Call
Form 10-Q

First Quarter

Sage Therapeutics Announces First Quarter 2019 Financial Results and Highlights Pipeline and Business Progress
Sage Therapeutics Q1 2019 Financial Results Conference Call
Form 10-Q

2018

Fourth Quarter

Sage Therapeutics Announces Fourth Quarter and Full Year 2018 Financial Results and Highlights Pipeline and Business Progress
Sage Therapeutics Q4 2018 Financial Results Conference Call
Form 10-K

Third Quarter

Sage Therapeutics Announces Third Quarter 2018 Financial Results and Highlights Pipeline and Business Progress
Sage Therapeutics Q3 2018 Financial Results Conference Call
Form 10-Q

Second Quarter

Sage Therapeutics Announces Second Quarter 2018 Financial Results and Highlights Pipeline and Business Progress
Sage Therapeutics Q2 2018 Financial Results Conference Call
Form 10-Q

First Quarter

Sage Therapeutics Q1 2018 Financial Results Conference Call
Sage Therapeutics Announces First Quarter 2018 Financial Results and Provides Update on Pipeline and Progress toward Launch Readiness
Form 10-Q

2017

Fourth Quarter

Sage Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Provides Pipeline Update
Sage Therapeutics Q4 2017 Financial Results
Form 10-K

Third Quarter

Sage Therapeutics Announces Third Quarter 2017 Financial Results and Provides Pipeline Update
Sage Therapeutics Q3 2017 Financial Results
Form 10-Q

Second Quarter

Sage Therapeutics Announces Second Quarter 2017 Financial Results and Provides Pipeline Update
Sage Therapeutics Q2 2017 Financial Results Conference Call
Form 10-Q

First Quarter

Sage Therapeutics Announces First Quarter 2017 Financial Results and Provides Pipeline Update
Sage Therapeutics Q1 2017 Financial Results Conference Call
Form 10-Q

2016

Fourth Quarter

Sage Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update
Sage Therapeutics Q4 2016 Financial Results Conference Call
Form 10-K

Third Quarter

Sage Therapeutics Q3 2016 Financial Results Conference Call
Form 10-Q

Second Quarter

SAGE Therapeutics Q2 2016 Financial Results Conference Call
Sage Therapeutics Announces Second Quarter 2016 Financial Results and Provides Corporate Update
Form 10-Q

First Quarter

Sage Therapeutics Announces First Quarter 2016 Financial Results
SAGE Therapeutics Q1 2016 Financial Results Conference Call
Form 10-Q

2015

Fourth Quarter

Sage Therapeutics Announces Fourth Quarter and Full Year 2015 Financial Results
SAGE Therapeutics Q4 2015 Financial Results Conference Call
Form 10-K

Third Quarter

SAGE Therapeutics Q3 2015 Financial Results Conference Call
SAGE Announces Third Quarter 2015 Financial Results and Recent Pipeline Progress
Form 10-Q

Second Quarter

SAGE Therapeutics Announces Second Quarter 2015 Financial Results and Highlights Recent Progress
Form 10-Q

First Quarter

SAGE Therapeutics Announces SAGE-547 Progress and First Quarter 2015 Financial Results
Form 10-Q

2014

Fourth Quarter

SAGE Therapeutics Reports Fourth Quarter and Full Year 2014 Financial Results
Form 10-K

Patients & Care Partners

Patient Advocacy
Patient Advocacy Sponsorships & Grants
Patient Support

Healthcare Providers

Visit the Sage Medical Hub

Our Medicines

Therapeutic Focus

A New Approach to Brain Health Disorders
GABA & NMDA Receptors

Programs & Research

Depression Franchise
Neurology Franchise
Neuropsychiatry Franchise
Pipeline
Clinical Trials
Collaborations

About Us

Mission & Values
Corporate Governance
Our Team
Partnering
Corporate Social Responsibility
Funding & Giving

Working at Sage

Sage Thoughts
Investors/Media
Clinical Trials
Contact Us

Facebook
Twitter
Instagram
LinkedIn

© Sage Therapeutics, Inc

Privacy Policy
Terms of Use
Community Guidelines
Accessibility
Site Map

SAGE THERAPEUTICS, ZULRESSO, and their respective logos, and SAGE CENTRAL are registered trademarks of Sage Therapeutics, Inc. ZURZUVAE is a trademark of Sage Therapeutics Inc. All other trademarks referenced herein are the property of their respective owners.